Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Bremerton-Silverdale, WA MSA — September 2026
Kitsap's tight labor market collides with a thin science talent pool.
Kitsap County unemployment fell to 3.5% in July — tighter than the state's 4.9% and the nation's 4.1% — while metro Clinical Research Associate pay climbed to $98,142, well above the $90,956 national median.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Kitsap County unemployment: 3.5% — vs 4.9% WA, 4.1% US (July/Aug 2026)
- Federal employment share: 22.9% — Highest of any WA county (ESD, 2025)
- WA life sciences employment growth: +1.9% — vs -0.3% national life sciences, 2024
- Seattle MSA pharma manufacturing R&D growth: +60% YoY — Median salary $190,500
Key takeaways
Clinical Research Associate pay is outrunning the national trend.
Metro CRA advertised pay sits at $98,142 versus a $90,956 national median, both marked up and significant in magnitude. A county unemployment rate well below state and national averages suggests employers are already paying up to secure clinical staff in a shallow local pool — a gap likely to widen further if Seattle-area trial activity continues drawing from the same labor shed.
Government job losses free up adjacent technical talent.
July's 500-job decline in Kitsap government payrolls, against a county where federal employment is unusually concentrated, may release regulatory, administrative, and technical staff with transferable skills. Life sciences employers hiring for regulatory affairs or quality functions should watch whether this pool shows up in applicant flow over the next hiring cycle.
Biostatistician pay is falling locally while rising nationally.
Metro Biostatistician advertised pay dropped moderately to $147,800 even as the national median climbed to $133,322, narrowing what had likely been a wider premium. This divergence may signal softening local demand or a shift toward remote/national hiring for data-heavy roles, reinforcing the case for outsourcing biostatistics work to CROs rather than building local headcount.
Lab Technician pay gap with national rates keeps widening.
Metro Lab Technician pay holds stable at $57,200 while the national median has dropped moderately to $47,402, a spread of roughly $10,000. Persistently elevated entry-level lab pay in this metro, against a softening national market, points to a structurally thinner regional supply of bench-level scientific staff rather than a temporary spike.
Median advertised pay by role — Bremerton-Silverdale, WA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $83,387 | $132,000 | $151,115 | Significant increase | $131,354 |
| Clinical Research Associate * | $75,806 | $98,142 | $108,750 | Significant increase | $90,956 |
| Lab Technician * | $46,540 | $57,200 | $67,954 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $72,732 | $110,677 | $118,815 | Stable | $104,000 |
| Clinical Data Manager * | $100,327 | $120,009 | $130,356 | Stable | $123,031 |
| Biostatistician * | $111,745 | $147,800 | $158,319 | Moderate decline | $133,322 |
| Validation Engineer * | $96,427 | $114,438 | $126,203 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Kitsap County's unemployment rate fell to 3.5% in July 2026 from 4.1% in June, outpacing both the state (4.9% August) and national (4.1% August) rates, even as overall county payrolls contracted by 300 jobs on a 500-job government pullback. Federal employment, which accounts for 22.9% of the county's labor force — the highest concentration of any Washington county — continues to anchor labor supply even as St. Michael Medical Center and other regional healthcare and research employers compete for a comparatively thin specialized talent pool outside the Seattle core.
What it means
Tight county-level unemployment combined with a federal-heavy labor base means Bremerton-area life sciences employers draw most specialized scientific, clinical, and regulatory talent from the broader Seattle-Tacoma labor shed rather than locally, making metro advertised pay for Research Scientist ($132,000) and Clinical Research Associate ($98,142) — both up and tracking above national medians — a more reliable signal of what it actually takes to compete than county wage averages. With Washington's life sciences sector growing 1.9% in employment even as national life sciences employment declined, Bremerton-area organizations may be underpricing the premium now required to pull candidates away from Seattle-area biotech and CDMO employers. Consider reviewing CRA and Research Scientist offers against Seattle-Tacoma corridor rates rather than local median wages when the role requires relocation or hybrid commuting into that labor market.
Looking ahead
Worth watching: MultiCare Health System's September WARN notice covering 138 workers statewide may touch Kitsap-area clinical and lab operations. Track whether affected healthcare workers with transferable clinical research or quality skills surface in life sciences applicant pools over the next two months.
Emerging pressure point: Washington's statewide unemployment rose to 4.7% in August against Kitsap County's much tighter 3.5% July reading, an unusual divergence. If this gap persists, Bremerton-area employers may find themselves competing harder than the state headline rate would suggest, particularly for scientific and regulatory roles sourced from the wider Puget Sound labor market.
Potential inflection point: Seattle MSA pharma manufacturing R&D employment grew 60% year-over-year with a median salary near $190,500, intensifying pull on Bremerton-adjacent talent. Watch whether this acceleration pulls CMC and manufacturing specialists out of the broader Kitsap/Olympic Peninsula labor shed over the next hiring cycle.
Expected: National biopharma layoffs continued in September (BioMarin, Bristol Myers) even as 64% of surveyed organizations kept actively recruiting. Expect continued bifurcation locally — consolidation-driven cuts at larger employers paired with sustained demand for execution-critical clinical and regulatory roles.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.